Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yongping Song
Zhengzhou University - Affiliated Cancer Hospital
Zhengzhou, Henan
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
81
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Sintilimab for Relapsed/Refractory Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial (ORIENT-4)
Number of pages: 22
Posted: 09 Apr 2020
Rong Tao
,
Lei Fan
, Yongping Song,
Yu Hu
,
Wei Zhang
,
Yafei Wang
,
Linxinyu Xu
,
Hui Zhou
,
Xing Sun
,
Wei Xu
and
Jianyong Li
Shanghai Jiao Tong University (SJTU), School of Medicine, Xin Hua Hospital, Department of Hematology, Nanjing Medical University - Collaborative Innovation Center for Cancer Personalized Medicine, Zhengzhou University - Affiliated Cancer Hospital, Huazhong University of Science and Technology - Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tianjin Medical University - Cancer Institute and Hospital, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd, Nanjing Medical University - Collaborative Innovation Center for Cancer Personalized Medicine and Shanghai University - Institute of ADR and Arbitration
Downloads
81
(796,622)
View PDF
Download
Abstract:
Extranodal NK/T-cell lymphoma; PD-1; relapse; refractory; sintilimab
Feedback